These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8484959)

  • 21. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes.
    Meira DD; Marinho-Carvalho MM; Teixeira CA; Veiga VF; Da Poian AT; Holandino C; de Freitas MS; Sola-Penna M
    Mol Genet Metab; 2005 Apr; 84(4):354-62. PubMed ID: 15781197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equilibrium partition studies of the myofibrillar interactions of glycolytic enzymes.
    Harris SJ; Winzor DJ
    Arch Biochem Biophys; 1989 Nov; 275(1):185-91. PubMed ID: 2530935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The binding of glycolytic enzymes to the cytoskeleton--influence of pH.
    Shearwin K; Masters C
    Biochem Int; 1990 Nov; 22(4):735-40. PubMed ID: 2150310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term streptozotocin diabetes on cytoskeletal and cytosolic phosphofructokinase and the levels of glucose 1,6-bisphosphate and fructose 2,6-bisphosphate in different rat muscles.
    Chen-Zion M; Livnat T; Beitner R
    Biochem Med Metab Biol; 1994 Dec; 53(2):137-44. PubMed ID: 7710770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic probes locate binding sites for the glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase, aldolase and phosphofructokinase on the actin monomer in microfilaments.
    Méjean C; Pons F; Benyamin Y; Roustan C
    Biochem J; 1989 Dec; 264(3):671-7. PubMed ID: 2482731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carbamylcholine and pyridostigmine on cytoskeleton-bound and cytosolic phosphofructokinase and ATP levels in different rat tissues.
    Glass-Marmor L; Chen-Zion M; Beitner R
    Gen Pharmacol; 1996 Oct; 27(7):1241-6. PubMed ID: 8981075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of phosphofructokinase action by macromolecular interactions. Quantitative analysis of the phosphofructokinase-aldolase-calmodulin system.
    Orosz F; Christova TY; Ovádi J
    Biochim Biophys Acta; 1988 Nov; 957(2):293-300. PubMed ID: 2973356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin-induced decrease in brain ATP, stimulation of brain anaerobic glycolysis and elevation of plasma hemoglobin; the protective action of calmodulin antagonists.
    Koren-Schwartzer N; Chen-Zion M; Ben-Porat H; Beitner R
    Gen Pharmacol; 1994 Oct; 25(6):1257-62. PubMed ID: 7875554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fructose 2,6-bisphosphate and glycolytic flux in skeletal muscle of swimming frog.
    Wegener G; Krause U; Thuy M
    FEBS Lett; 1990 Jul; 267(2):257-60. PubMed ID: 2143142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between glycolytic enzymes and cytoskeletal structure--the influence of ionic strength and molecular crowding.
    Shearwin K; Nanhua C; Masters C
    Biochem Int; 1990; 21(1):53-60. PubMed ID: 2143653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [State of the glycolytic system in the hypertrophied heart].
    Larionov NP
    Vopr Med Khim; 1978; 24(1):7-11. PubMed ID: 149427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
    Orosz F; Telegdi M; Liliom K; Solti M; Korbonits D; Ovádi J
    Mol Pharmacol; 1990 Dec; 38(6):910-6. PubMed ID: 2147457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glycolytic activity of rat skeletal muscle during the early postnatal period of development].
    Larionov NP; Krotenko NM
    Vopr Med Khim; 1976; 22(5):603-8. PubMed ID: 138256
    [No Abstract]   [Full Text] [Related]  

  • 34. CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity.
    Norman JA; Ansell J; Stone GA; Wennogle LP; Wasley JW
    Mol Pharmacol; 1987 May; 31(5):535-40. PubMed ID: 3033469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-type 6-phosphofructo-1-kinase and aldolase associate conferring catalytic advantages for both enzymes.
    Marcondes MC; Sola-Penna M; Torres Rda S; Zancan P
    IUBMB Life; 2011 Jun; 63(6):435-45. PubMed ID: 21698747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of rat cerebral glycolytic enzymes to hyperammonemic states.
    Ratnakumari L; Murthy CR
    Neurosci Lett; 1993 Oct; 161(1):37-40. PubMed ID: 8255543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldolase decreases the dissociation-induced inactivation of muscle phosphofructokinase.
    Orosz F; Christova TY; Ovádi J
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1121-8. PubMed ID: 2959283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in glucose 1,6-bisphosphate levels, activation of phosphofructokinase and phosphoglucomutase, and inhibition of glucose 1,6-bisphosphatase in muscle induced by trifluoperazine.
    Frucht H; Kaplansky M; Beitner R
    Biochem Med; 1984 Feb; 31(1):122-9. PubMed ID: 6331422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations on the activity of glycolytic erythrocytic enzymes in polycythemia vera.
    Zatoński W; Kwiatkowska J; Baranowski T; Tawlas N
    Pol Med J; 1971; 10(4):819-22. PubMed ID: 4256716
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on glycolysis of red blood cells in anemias. I. Congenital microspherocytosis.
    Boguslawska-Jaworska J; Kwiatkowska J; Baranowski T
    Arch Immunol Ther Exp (Warsz); 1966; 14(4):478-83. PubMed ID: 4224068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.